I don’t see a long-drawn patch. I think it is more tactical right now because large markets are moving very fast and India was a consensus overweight. In fact, it wasn’t a consensus overweight till about third quarter of last year because we were seeing continuous FII outflows.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.